Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22925258 | 0.96 | GPR3 (0.37) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL22925346 | 0.87 | MAPT (0.33) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL24000284 | 0.84 | GPR3 (0.44) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL22925347 | 0.83 | GPR3 (0.38) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL22505992 | 0.82 | KDM4E (0.32) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL23308847 | 0.81 | CYP1A1 (0.45) | KDM4EMAPTCYP1A2RAB9A | |
| SCHEMBL23308820 | 0.81 | CYP1B1 (0.41) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL24000289 | 0.81 | MAPT (0.42) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL19660382 | 0.81 | GPR3 (0.38) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 | |
| SCHEMBL19660379 | 0.81 | GPR3 (0.38) | KDM4EL3MBTL1ALDH1A1MAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, SLC39A11 | KDM4E 1966/4885L3MBTL1 237/4885ALDH1A1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.